Ambev S.A. (NYSE:ABEV) Shares Sold by Mraz Amerine & Associates Inc.

Mraz Amerine & Associates Inc. lessened its stake in Ambev S.A. (NYSE:ABEV) by 6.3% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 712,757 shares of the company’s stock after selling 47,637 shares during the quarter. Mraz Amerine & Associates Inc.’s holdings in Ambev were worth $1,739,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of ABEV. HTLF Bank purchased a new stake in Ambev in the third quarter valued at $26,000. Lake Street Advisors Group LLC purchased a new stake in Ambev during the first quarter worth about $28,000. Riversedge Advisors LLC acquired a new stake in shares of Ambev during the third quarter worth about $31,000. Foster Group Inc. purchased a new position in shares of Ambev in the third quarter valued at approximately $33,000. Finally, Private Advisor Group LLC acquired a new position in shares of Ambev in the third quarter valued at approximately $34,000. Hedge funds and other institutional investors own 8.13% of the company’s stock.

Ambev Stock Performance

NYSE:ABEV opened at $2.28 on Friday. Ambev S.A. has a 12 month low of $2.01 and a 12 month high of $3.00. The company has a debt-to-equity ratio of 0.02, a current ratio of 1.11 and a quick ratio of 0.78. The firm has a market capitalization of $35.84 billion, a PE ratio of 11.97, a price-to-earnings-growth ratio of 5.34 and a beta of 1.05. The business’s fifty day moving average price is $2.35 and its 200 day moving average price is $2.26.

Ambev (NYSE:ABEV) last released its quarterly earnings data on Thursday, August 1st. The company reported $0.03 EPS for the quarter, meeting analysts’ consensus estimates of $0.03. The business had revenue of $3.85 billion for the quarter, compared to the consensus estimate of $3.56 billion. Ambev had a return on equity of 16.94% and a net margin of 17.93%. During the same quarter in the prior year, the business posted $0.03 EPS. On average, sell-side analysts anticipate that Ambev S.A. will post 0.17 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities analysts have commented on the stock. UBS Group decreased their price target on shares of Ambev from $3.20 to $2.90 and set a “buy” rating for the company in a research report on Wednesday, July 31st. StockNews.com began coverage on Ambev in a research note on Friday, October 18th. They set a “buy” rating for the company. Four investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $2.75.

Ambev Company Profile

Ambev SA, through its subsidiaries, engages in the production, distribution, and sale of beer, draft beer, carbonated soft drinks, malt and food, other alcoholic beverages, and non-alcoholic and non-carbonated products in Brazil, Central America and Caribbean, Latin America South, and Canada. It offers beer primarily under the Skol, Brahma, Antarctica, Brahva, Budweiser, Bud Light, Beck, Leffe, Hoegaarden, Balboa ICE, Balboa, Atlas Golden Light, Atlas, Bucanero, Cristal, Mayabe, Presidente, Presidente Light, Brahma Light, Bohemia, The One, Corona, Modelo Especial, Stella Artois, Quilmes Clásica, Paceña, Taquiña, Huari, Becker, Cusqueña, Michelob Ultra, Busch, Pilsen, Ouro Fino, Bud 66, Banks, Deputy, Patricia, Labatt Blue, Alexander Keith’s, and Kokanee brands.